The recall affects 15mg/ml (75 mg/5ml) nizatidine oral solutions packaged in 480 ml bottles the ndc number for the recalled medication is 60846-301-15 with lot numbers that include 06598004a. Acid reflux med recall. The recalls, posted by the food and drug administration (fda) this week, are the latest in a series that began in september 2019, when the fda alerted the public to the presence of a probable human carcinogen, n-nitrosodimethylamine (ndma), in some ranitidine medications ranitidine is the generic form of zantac.
acid reflux med recall
Mylan nv also announced a recall on wednesday of three lots of nizatidine, which is used to treat duodenal ulcers and acid reflux trace amounts of ndma were found in the drug, which was. The heartburn medications in the recall all contain the ingredient ranitidine. it's an acid reducer to lessen the frequency and severity of heartburn. it's also used to treat stomach ulcers.. These medications work to prevent heartburn and provide relief tied to acid ingestion by reducing the amount of acid the stomach makes. the prescription version is used to treat and prevent ulcers of the stomach; it also treats gastroesophageal reflux disease (gerd). this recall was recently expanded to include the following products:.
0 comments:
Post a Comment